Reprogramming the Genome: Applications of Crispr-Cas in Non-Mammalian Systems Part a: Volume 179

ISBN-13: 9780323853217 / Angielski / Twarda / 2021 / 242 str.

Vijai Singh

Spis treści

1. An introduction and use of the CRISPR-Cas systems Vijai Singh

2. History, evolution and classification of CRISPR-Cas associated systems Nisheeth Agarwal and Radhika Gupta

3. CRISPR based bacterial genome editing and removal of pathogens Ravi Jothi, Chandrasekar Karthika, Arumugam Kamaladevi, Lakkakula Satish, Shunmugiah Karutha Pandian and Shanmugaraj Gowrishankar

4. CRISPR based genome editing and removal of human viruses Yuan-Chuan Chen

5. CRISPR based development of RNA editing and the diagnostic platform Lakkakula Satish, Gunamalai Lavanya, Thirupathi Kasthuri, Aruchamy Kalaivaani, Sasanala Shamili, Muthuramalingam Pandian, Shanmugaraj Gowrishankar, Shunmugiah Karutha Pandian, Vijai Singh, Yaron Sitrit and Ariel Kushmaro

6. CRISPR-based pathogenic fungal genome editing for control of infection and disease Takayuki Arazoe

7. Genome engineering in insects for the control of vector borne diseases V. Edwin Hillary and S. Antony Ceasar

O autorze

Dr Vijai Singh is an Associate Professor and Dean (Research & Innovation) at School of Sciences, Indrashil University, Rajpur, Mehsana, Gujarat, India. He was an Assistant Professor in the Department of Biological Sciences and Biotechnology at the Institute of Advanced Research, Gandhinagar, India and also an Assistant Professor in the Department of Biotechnology at the Invertis University, Bareilly, India. Prior to that, he was a Postdoctoral Fellow in the Synthetic Biology Group at the Institute of Systems and Synthetic Biology, Paris, France and School of Energy & Chemical Engineering at the Ulsan National Institute of Science and Technology, Ulsan, South Korea. He received his Ph.D. in Biotechnology (2009) from the National Bureau of Fish Genetic Resources, Uttar Pradesh Technical University, Lucknow, India with a research focus on the development of molecular and immunoassays for diagnosis of Aeromonas hydrophila. His research interests are focused on building novel biosynthetic pathways for production of medically and industrially important biomolecules. Additionally, his laboratory is working on CRISPR-Cas9 tools for genome editing. He has more than 8 years of research and teaching experience in synthetic biology, metabolic engineering, bioinformatics, microbiology, and industrial microbiology. He has published 79 articles, 51 chapters, 15 books and 4 patents. He serves as an associate editor, editorial board member, and reviewer of several peer-reviewed journals. He is also a member of the Board of Study and Academic Council of Indrashil University and is the Member Secretary of the Institutional Biosafety Committee (IBSC) at the same University.